Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иван МУРГОВ, Запряна ДЕНКОВАfiledCriticalИван МУРГОВ
Priority to BG100214ApriorityCriticalpatent/BG61799B1/en
Publication of BG100214ApublicationCriticalpatent/BG100214A/en
Publication of BG61799B1publicationCriticalpatent/BG61799B1/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
The method can be applied in the pharmaceutical and the dairy industries for the preparation of probiotic for the prevention and treatment of colibacteriosis, oedema disease, gastrointestinal infections, diarrhoea and dysbacteriosis in mammals, birds and humans. By a method hybrid strain Lactobacillus RAB-8, registered in NBIMCC under No. 2416, is cultivated in the liquid nutritive medium of suitable acidity, temperature and anaerobiosis.
BG100214A1995-12-111995-12-11Method for the preparation of probiotic
BG61799B1
(en)
Influence of the oral administration of different lactic acid bacteria on intestinal microflora and iga‐secreting cells in mice treated with ampicillin
Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
CONSORTIUM OF BACTERIA (STREPTOCOCCUS THERMOPHILUS, STREPTOCOCCUS FOVIS, LACTOBACILLUS SALIVARIUS VAR, SALICINICUS, LACTOBACILLUS SALIVARIUS VAR.SALIVARIUS, LACTOBACUSUS ACIDOBHILUSHIELAHIELA 2014, a LACTOBIUSHIELAAAAAAAAAAAAAAAAAAAAAAAAA, a, aus